Concepts (152)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fluorodeoxyglucose F18 | 13 | 2024 | 146 | 2.130 |
Why?
|
| Positron-Emission Tomography | 14 | 2024 | 354 | 1.520 |
Why?
|
| Lung Neoplasms | 8 | 2024 | 2457 | 0.720 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 5 | 2024 | 1173 | 0.680 |
Why?
|
| Radiopharmaceuticals | 6 | 2020 | 217 | 0.650 |
Why?
|
| Cardiomyopathies | 3 | 2022 | 315 | 0.410 |
Why?
|
| Cysts | 2 | 2010 | 100 | 0.360 |
Why?
|
| Solitary Pulmonary Nodule | 2 | 2010 | 141 | 0.350 |
Why?
|
| Amyloid Neuropathies, Familial | 2 | 2022 | 52 | 0.350 |
Why?
|
| Positron Emission Tomography Computed Tomography | 2 | 2024 | 107 | 0.330 |
Why?
|
| Tomography, X-Ray Computed | 9 | 2015 | 2668 | 0.310 |
Why?
|
| Duodenal Diseases | 1 | 2010 | 26 | 0.310 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 2 | 2023 | 195 | 0.310 |
Why?
|
| Multimodal Imaging | 3 | 2015 | 117 | 0.290 |
Why?
|
| Whole Body Imaging | 4 | 2015 | 40 | 0.260 |
Why?
|
| Prognosis | 6 | 2026 | 4116 | 0.250 |
Why?
|
| Technetium | 2 | 2022 | 21 | 0.240 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2016 | 1307 | 0.230 |
Why?
|
| Tumor Burden | 6 | 2023 | 333 | 0.230 |
Why?
|
| 5-Methylcytosine | 1 | 2026 | 134 | 0.220 |
Why?
|
| X-linked Nuclear Protein | 1 | 2024 | 11 | 0.220 |
Why?
|
| Radionuclide Imaging | 4 | 2018 | 183 | 0.210 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2026 | 116 | 0.210 |
Why?
|
| Co-Repressor Proteins | 1 | 2024 | 26 | 0.210 |
Why?
|
| Receptors, Peptide | 1 | 2024 | 32 | 0.210 |
Why?
|
| Aged | 14 | 2026 | 21760 | 0.210 |
Why?
|
| Subtraction Technique | 3 | 2011 | 126 | 0.210 |
Why?
|
| Molecular Chaperones | 1 | 2024 | 125 | 0.200 |
Why?
|
| Intestinal Neoplasms | 1 | 2024 | 77 | 0.200 |
Why?
|
| Retrospective Studies | 9 | 2024 | 10962 | 0.190 |
Why?
|
| Aged, 80 and over | 5 | 2024 | 7387 | 0.180 |
Why?
|
| Mononeuropathies | 1 | 2022 | 8 | 0.180 |
Why?
|
| Erythrocytes | 1 | 2003 | 242 | 0.180 |
Why?
|
| Neuroendocrine Tumors | 1 | 2024 | 157 | 0.180 |
Why?
|
| Pulmonary Artery | 1 | 2024 | 342 | 0.180 |
Why?
|
| Colitis, Ulcerative | 1 | 2009 | 824 | 0.180 |
Why?
|
| Multiple Myeloma | 1 | 2026 | 369 | 0.170 |
Why?
|
| Female | 20 | 2026 | 51570 | 0.170 |
Why?
|
| Male | 20 | 2026 | 47109 | 0.170 |
Why?
|
| Middle Aged | 13 | 2024 | 29442 | 0.170 |
Why?
|
| Stomach Neoplasms | 1 | 2024 | 319 | 0.170 |
Why?
|
| Humans | 30 | 2026 | 98135 | 0.160 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2024 | 682 | 0.160 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2003 | 244 | 0.160 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2018 | 642 | 0.160 |
Why?
|
| Sarcoidosis | 1 | 2020 | 93 | 0.150 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2020 | 151 | 0.150 |
Why?
|
| Image Enhancement | 3 | 2014 | 503 | 0.150 |
Why?
|
| Tachycardia, Ventricular | 1 | 2020 | 180 | 0.140 |
Why?
|
| Pancreatic Neoplasms | 1 | 2024 | 769 | 0.140 |
Why?
|
| Bone and Bones | 3 | 2011 | 270 | 0.130 |
Why?
|
| Parkinsonian Disorders | 1 | 2016 | 24 | 0.120 |
Why?
|
| Diagnosis, Computer-Assisted | 2 | 2011 | 339 | 0.120 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2016 | 40 | 0.120 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2011 | 462 | 0.120 |
Why?
|
| Mutation | 2 | 2024 | 4392 | 0.110 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2016 | 98 | 0.110 |
Why?
|
| Neuroblastoma | 1 | 2018 | 409 | 0.110 |
Why?
|
| Cystic Duct | 1 | 2014 | 5 | 0.110 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 1 | 2014 | 9 | 0.110 |
Why?
|
| Liver Transplantation | 1 | 2022 | 1235 | 0.110 |
Why?
|
| Gallbladder | 1 | 2014 | 33 | 0.110 |
Why?
|
| Cholecystitis, Acute | 1 | 2014 | 10 | 0.110 |
Why?
|
| Diagnosis, Differential | 2 | 2024 | 1568 | 0.100 |
Why?
|
| Adult | 9 | 2024 | 29564 | 0.100 |
Why?
|
| Gadolinium DTPA | 1 | 2014 | 239 | 0.100 |
Why?
|
| Aspartic Acid | 1 | 2013 | 62 | 0.100 |
Why?
|
| Prealbumin | 2 | 2022 | 46 | 0.090 |
Why?
|
| Sirolimus | 1 | 2013 | 182 | 0.090 |
Why?
|
| Predictive Value of Tests | 3 | 2024 | 1784 | 0.090 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2013 | 158 | 0.090 |
Why?
|
| Biomarkers, Tumor | 2 | 2026 | 1764 | 0.080 |
Why?
|
| False Negative Reactions | 1 | 2010 | 59 | 0.080 |
Why?
|
| Pituitary Neoplasms | 1 | 2010 | 74 | 0.070 |
Why?
|
| Immunotherapy, Adoptive | 2 | 2023 | 327 | 0.070 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2013 | 384 | 0.070 |
Why?
|
| Radiosurgery | 1 | 2012 | 351 | 0.070 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2013 | 401 | 0.070 |
Why?
|
| Artificial Intelligence | 2 | 2011 | 473 | 0.070 |
Why?
|
| Prospective Studies | 4 | 2026 | 4825 | 0.070 |
Why?
|
| Bone Neoplasms | 2 | 2010 | 316 | 0.070 |
Why?
|
| Kidney Neoplasms | 1 | 2013 | 556 | 0.070 |
Why?
|
| Echo-Planar Imaging | 1 | 2007 | 49 | 0.070 |
Why?
|
| Remission Induction | 1 | 2009 | 754 | 0.060 |
Why?
|
| Brain Neoplasms | 1 | 2013 | 842 | 0.060 |
Why?
|
| Brain Diseases | 1 | 2007 | 175 | 0.060 |
Why?
|
| Neoplasm Staging | 3 | 2018 | 2080 | 0.060 |
Why?
|
| Pattern Recognition, Automated | 1 | 2007 | 218 | 0.060 |
Why?
|
| Young Adult | 3 | 2018 | 7511 | 0.050 |
Why?
|
| Octreotide | 1 | 2024 | 32 | 0.050 |
Why?
|
| Foreign-Body Migration | 1 | 2024 | 32 | 0.050 |
Why?
|
| Neoplasm Metastasis | 3 | 2013 | 1089 | 0.050 |
Why?
|
| Fibrin | 1 | 2024 | 86 | 0.050 |
Why?
|
| Catheters, Indwelling | 1 | 2024 | 102 | 0.050 |
Why?
|
| Vascular Calcification | 1 | 2024 | 48 | 0.050 |
Why?
|
| Reproducibility of Results | 3 | 2018 | 2787 | 0.050 |
Why?
|
| Digestive System | 1 | 2003 | 42 | 0.050 |
Why?
|
| Technetium Tc 99m Pyrophosphate | 1 | 2022 | 8 | 0.050 |
Why?
|
| Diphosphates | 1 | 2022 | 15 | 0.050 |
Why?
|
| Device Removal | 1 | 2024 | 170 | 0.050 |
Why?
|
| Angiography | 1 | 2003 | 194 | 0.050 |
Why?
|
| Inflammation | 1 | 2009 | 1120 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 2373 | 0.040 |
Why?
|
| Biomarkers | 2 | 2022 | 2022 | 0.040 |
Why?
|
| Histiocytes | 1 | 2021 | 22 | 0.040 |
Why?
|
| Pulmonary Embolism | 1 | 2024 | 234 | 0.040 |
Why?
|
| Adolescent | 2 | 2018 | 10097 | 0.040 |
Why?
|
| Prevalence | 2 | 2020 | 1383 | 0.040 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2021 | 62 | 0.040 |
Why?
|
| Antigens, CD19 | 1 | 2021 | 90 | 0.040 |
Why?
|
| Survival Rate | 2 | 2015 | 2041 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2024 | 9713 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2007 | 2585 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2022 | 522 | 0.040 |
Why?
|
| 3-Iodobenzylguanidine | 1 | 2018 | 20 | 0.040 |
Why?
|
| Reference Standards | 1 | 2018 | 146 | 0.030 |
Why?
|
| Observer Variation | 2 | 2010 | 579 | 0.030 |
Why?
|
| Neoplasms | 1 | 2012 | 3334 | 0.030 |
Why?
|
| Trinucleotide Repeats | 1 | 2016 | 30 | 0.030 |
Why?
|
| Calcium Channels, N-Type | 1 | 2016 | 40 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 1535 | 0.030 |
Why?
|
| Corpus Striatum | 1 | 2016 | 83 | 0.030 |
Why?
|
| Calcium Channels | 1 | 2016 | 180 | 0.030 |
Why?
|
| ROC Curve | 2 | 2007 | 795 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 1327 | 0.030 |
Why?
|
| Everolimus | 1 | 2013 | 35 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 903 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2013 | 271 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2016 | 1996 | 0.020 |
Why?
|
| Infant | 1 | 2018 | 3332 | 0.020 |
Why?
|
| Algorithms | 2 | 2011 | 2009 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2018 | 4006 | 0.020 |
Why?
|
| Biological Transport | 1 | 2011 | 401 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2010 | 118 | 0.020 |
Why?
|
| Contrast Media | 1 | 2014 | 1011 | 0.020 |
Why?
|
| Pineal Gland | 1 | 2007 | 16 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2015 | 3213 | 0.020 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2011 | 322 | 0.020 |
Why?
|
| Texas | 1 | 2007 | 136 | 0.020 |
Why?
|
| Bone Diseases | 1 | 2007 | 50 | 0.020 |
Why?
|
| Child | 1 | 2018 | 7699 | 0.020 |
Why?
|
| Reference Values | 1 | 2007 | 612 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2006 | 215 | 0.010 |
Why?
|
| Automation | 1 | 2006 | 118 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 4026 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 1948 | 0.010 |
Why?
|
| Time Factors | 1 | 2011 | 5576 | 0.010 |
Why?
|
| Software | 1 | 2006 | 695 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 3618 | 0.010 |
Why?
|
| Lung | 1 | 2006 | 1407 | 0.010 |
Why?
|
| Brain | 1 | 2007 | 2448 | 0.010 |
Why?
|
| Risk Factors | 1 | 2007 | 6232 | 0.010 |
Why?
|